Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Prevention of Venous Thromboembolism × Rivaroxaban × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Neoplasms 10 Venous Thromboembolism 7 Venous Thrombosis 3 Treatment of Venous Thromboembolism in Cancer Patients 3 Pulmonary Embolism 3 Upper Extremity Deep Vein Thrombosis 2 Thrombosis 1 Recurrence 1 Prevention of Venous Thromboembolism 1 Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery 1 Myeloproliferative Disorders 1 Lung Neoplasms 1 Hemorrhage 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03055026 2022-03-11

PRO-LAPSII

Fadoi Foundation, Italy

Phase 3 Completed

Classical hematology

Prevention of Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡